Vireo Growth Business Summary

Vireo Growth Inc. (OTCQX: VREOF) operates as a vertically integrated cannabis multi-state operator (MSO) that generates revenue through the cultivation, manufacturing, and distribution of medical and adult-use cannabis products. The company’s primary business segments include retail sales via its Green Goods dispensary network and wholesale distribution of proprietary brands to third-party retailers. Following its transformational 2025 acquisition of Eaze Inc., Vireo has significantly expanded its revenue model to include high-margin delivery technology and logistics services. As of March 2026, the company maintains a massive operational footprint across 10 states, including core markets in Minnesota, Maryland, Florida, and California. Vireo competes directly with major MSOs such as Verano Holdings, Cresco Labs, and Trulieve Cannabis Corp., positioning itself as a top-tier consolidator in the U.S. market by leveraging distressed asset acquisitions and a technology-driven delivery platform to capture superior market share in high-growth regions. The company was founded in 2014 by Kyle Kingsley, M.D., a former emergency medicine physician who remains a central figure as Founder and Co-Executive Chairman. The current leadership team is led by CEO and Co-Executive Chairman John Mazarakis, a co-founder of Chicago Atlantic with over 20 years of experience in real estate and hospitality, who took the helm in late 2024 to spearhead the company's aggressive M&A strategy. Other key executives include President Amber Shimpa, a founding member who oversees core state operations, and CFO Tyson Macdonald, who brings over two decades of corporate development expertise from Acreage Holdings and Cloud Cannabis. The board is further strengthened by independent directors such as Victor E. Mancebo and Judd Nordquist, with Chris Hagedorn of ScottsMiracle-Gro expected to join following the Hawthorne Gardening Company acquisition. Notable institutional backing is provided by Chicago Atlantic, which has been instrumental in financing the company’s recent expansion and debt restructuring.